Jason Fredette | Senior Vice President, Investor Relations and Corporate Communications |
Anna Protopapas | President and Chief Executive Officer |
Arvin Yang | Chief Medical Officer |
Brian DeSchuytner | Chief Financial Officer |
Brian Cheng | J.P. Morgan |
Jonathan Chang | SVB Securities |
Colleen Kusy | Baird |
Kaveri Pohlman | BTIG |
Ashiq Mubarack | Citi |
Boris Peaker | Cowen |
Asthika Goonewardene | Truist |
David Nierengarten | Wedbush Securities |
Good morning, and welcome to Mersana Therapeutics First Quarter 2023 Conference Call and Webcast. Currently, all participants are in listen-only mode. There will be a question-and-answer session at the end of this call. Please note, this event is being recorded.
I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications.